Tag: allogeneic cell therapy market forecast

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the allogeneic cell therapy market size evolved in recent years?

The allogeneic cell therapy market will grow from $1.08 billion in 2024 to $1.2 billion in 2025 at a CAGR of 11.9%. This is due to increased focus on tailoring donor cell selection and genetic modifications, population growth, the global burden of chronic diseases, greater awareness, and more collaborations for biosimilar development.

What are the predictions for the allogeneic cell therapy market size in the coming years?

The allogeneic cell therapy market is projected to reach $1.86 billion by 2029, growing at a CAGR of 11.5%. The growth is driven by a demand for advanced medical treatments, novel cell therapies, a rising number of clinical trials, and increasing income levels. Trends include technology advancements, partnerships, mergers and acquisitions, and new product launches.

Get your allogeneic cell therapy market report here!

https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report

What key factors are fueling the growth of the allogeneic cell therapy market?

The rise in chronic diseases is expected to drive the growth of the allogeneic cell therapy market. Chronic diseases, often related to lifestyle changes, genetics, and exposure to harmful substances, are becoming more prevalent. Allogeneic cell therapy, which uses healthy donor cells to treat various chronic diseases, holds significant potential. In January 2023, the National Center for Biotechnology Information projected that the number of individuals aged 50 and above with chronic illnesses in the U.S. will nearly double by 2050, driving growth in the allogeneic cell therapy market.

How is the global allogeneic cell therapy market divided into key segments?

The allogeneic cell therapy market covered in this report is segmented –

1) By Type: Stem Cell Therapies, Non-Stem Cell Therapies

2) By Therapeutic Area: Hematological Disorders, Dermatological Disorders, Other Therapeutic Area

3) By End User: Hospitals, Specialty Clinics, Research Organizations

Subsegments:

1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells), Mesenchymal Stem Cell Therapy (MSC-Based Therapies), Induced Pluripotent Stem Cells (iPSC-Based Therapies), Neural Stem Cell Therapy, Other Stem Cell Therapies

2) By Non-Stem Cell Therapies: T-cell Therapies, Natural Killer (NK) Cell Therapies, Dendritic Cell Therapies, Other Non-Stem Cell Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp

Who are the key firms paving the way for growth in the allogeneic cell therapy market?

Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, TrakCel Ltd., Promab Biotechnologies Inc., Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Minerva Biotechnologies Corporation, Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG

Which trends are expected to transform the allogeneic cell therapy market?

Companies in the allogeneic cell therapy market are developing cell processing platforms to improve their market position. These platforms are designed to prepare and manipulate cells for therapeutic use, including isolation, purification, and expansion. For example, in March 2024, Getinge, a Swedish healthcare company, partnered with CellRev, a UK-based biotechnology firm, to launch Livit ACE, a continuous cell processing platform. This platform integrates advanced automation and bioprocessing technologies, enabling efficient, scalable cell production. Key features include state-of-the-art systems for cell isolation and purification, robust expansion capabilities, and advanced genetic modification tools to enhance cell engineering.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15976

What regions are contributing significantly to the growth of the allogeneic cell therapy market?

North America was the largest region in the allogeneic cell therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

GMP Cell Therapy Consumables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report

Stem Cell Therapy Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/stem-cell-therapy-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Expected Growth Rate of the Allogeneic Cell Therapy Market Based on Industry Projections?

The market for allogeneic cell therapy has witnessed a significant expansion in recent years. It is projected to rise from $1.08 billion in 2024 to hit the $1.2 billion mark in 2025, indicating a compound annual growth rate (CAGR) of 11.9%. Several factors have driven this growth during the past years, including the intensifying focus on individualizing donor cell selection and genetic modifications, a growing global population, a rise in chronic diseases worldwide, heightened awareness, and an uptick in collaborations geared towards the development of biosimilars.

The market size for allogeneic cell therapy is projected to experience a swift expansion in the approaching years. The market is anticipated to grow to $1.86 billion by 2029, at a compound annual growth rate (CAGR) of 11.5%. This forecasted growth can be credited to factors such as the rising demand for sophisticated medical treatments, an increase in demand for innovative allogeneic cell therapies, a higher number of clinical trials, larger patient population contributions, and increased income levels. Key trends expected during the forecast period consist of technological advancements, strategic partnerships, large-scale companies working with others, mergers and buyouts, and the introduction of new products.

How Are the key drivers Contributing to the Expansion of the Allogeneic Cell Therapy Market?

The surge in chronic diseases is anticipated to fuel the expansion of the allogeneic cell therapy market. Chronic illness, typically requiring ongoing medical care and often hampering everyday activities or life quality, is a long-term condition. The rise in such conditions is attributed to altered habits, heredity, and exposure to chemicals, pollutants, and toxins in the environment. Allogeneic cell therapy serves as a vital tool to treat a broad array of chronic diseases by using healthy donor cells to repair, replace, or modulate the unfunctional recipient cells or tissues. In January 2023, for example, the National Center for Biotechnology Information (NCBI), a medicine library based in the U.S., projected a 99.5% increase in the number of individuals aged 50 and above suffering from one or more chronic diseases by 2050, rising from 71.52 million in 2020 to 142.66 million. Consequently, the escalating occurrence of chronic diseases propels the growth of the allogeneic cell therapy market.

Get Your Free Sample of the Global Allogeneic Cell Therapy Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp

What Companies Are At the Forefront of Innovation in the Allogeneic Cell Therapy Market?

Major companies operating in the allogeneic cell therapy market are:

• Novartis AG

• Bristol Myers Squibb Company

• Takeda Pharmaceutical Company Limited

• Bluebird Bio Inc.

• Poseida Therapeutics Inc.

How Are Emerging Trends in Consumer Behavior Affecting the Allogeneic Cell Therapy Market?

Main players in the allogeneic cell therapy market are honing their focus on crafting innovative strategies such as cell processing platforms to fortify their market stand. Cell processing platforms are comprised of systems and techniques for preparing and altering cells for therapeutic uses, including cell isolation, purification, expansion, modification, and quality assurance to guarantee the cells are apt for clinical utilization. Take for example, healthcare firm Getinge from Sweden collaborated with UK’s biotechnology entity, CellRev, in March 2024 to launch a continuous cell processing platform known as Livit ACE (Adherent Cell Expansion). This trailblazing platform harmonizes advanced automation with bioprocessing technologies, immensely boosting the efficacy and scalability of cell production. The platform’s unique attributes consist of cutting-edge cell isolation and purification systems, ensuring optimum cell purity and viability, robust expansion mechanisms for mass production of therapeutic cells, advanced genetic modification tools for accurate cell engineering, and stringent quality control procedures to certify the safety and efficiency of the cell products.

Get Instant Access to the Global Allogeneic Cell Therapy Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Allogeneic Cell Therapy Market?

The allogeneic cell therapy market covered in this report is segmented –

1) By Type: Stem Cell Therapies, Non-Stem Cell Therapies

2) By Therapeutic Area: Hematological Disorders, Dermatological Disorders, Other Therapeutic Area

3) By End User: Hospitals, Specialty Clinics, Research Organizations

Subsegments:

1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells), Mesenchymal Stem Cell Therapy (MSC-Based Therapies), Induced Pluripotent Stem Cells (iPSC-Based Therapies), Neural Stem Cell Therapy, Other Stem Cell Therapies

2) By Non-Stem Cell Therapies: T-cell Therapies, Natural Killer (NK) Cell Therapies, Dendritic Cell Therapies, Other Non-Stem Cell Therapies

What Regions Are Propelling Growth in the Allogeneic Cell Therapy Industry?

North America was the largest region in the allogeneic cell therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Parameters Define the Allogeneic Cell Therapy Market’s Scope?

Allogeneic cell therapy is a treatment in which cells are harvested from a donor and used to treat a different individual (the recipient). These therapies are designed to replace or repair damaged tissues, modulate immune responses, or treat diseases such as cancer, genetic disorders, and autoimmune conditions.

Browse Through More Similar Reports By The Business Research Company:

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

GMP Cell Therapy Consumables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report

Stem Cell Therapy Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/stem-cell-therapy-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: